Entries by Organicell

Organicell Regenerative Medicine Inc. Provides Update On Operations and Financial Reporting Status

MIAMI, Jan. 21, 2020 (GLOBE NEWSWIRE) — Organicell Regenerative Medicine Inc.(OTCPK:BPSR) (the “Company”) is pleased to provide shareholders and the investment community with an update on operations. Since November 2018, the Company has remained focused on research and development activities and sale and distribution of anti-aging and cellular therapy derived products. In February 2019, the […]

Organicell Regenerative Medicine Inc., Biotech Products Services and Research, Inc. Update for Shareholders

Biotech Products Services and Research, Inc. operating as Organicell Regenerative Medicine Inc. (OTC: BPSR), today is providing its shareholders with an update on the Company’s progress. As previously announced, on April 23, 2018, Management and Business Associates, LLC, a company controlled by Mr. Manuel Iglesias, acquired 51% of the Company and Mr. Iglesias became our […]